GlassScriptPhysician profile
Laurence B Pearl
NPI 1386618841
$48,172.62
in general payments reported to CMS, 2019-2025
17 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,137 · 2020: $306 · 2021: $87.80 · 2022: $68.41 · 2023: $254 · 2024: $25K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $44K · Food and Beverage: $2,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $44,000.00 |
| Food and Beverage | $2,573.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $46,191.49 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $629.86 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip |
| Tela Bio, INC. | $239.44 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baxter Healthcare | $193.25 | 2024-2025 | Perclot |
| W. L. Gore & Associates, INC. | $133.85 | 2019 | |
| Kci USA, INC. | $122.51 | 2021-2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Boston Scientific Corporation | $116.64 | 2025 | Axios |
| Solventum Corporation | $108.18 | 2025 | V.A.C.Ulta, V.A.C. Veraflo |
| Covidien LP | $98.66 | 2019 | |
| Convatec INC. | $89.28 | 2021-2022 | |
| Acell, INC. | $54.30 | 2020 | |
| Conmed Corporation | $53.62 | 2019 | |
| Smith+Nephew, INC. | $44.41 | 2021-2022 | |
| Integra Lifesciences Corporation | $30.43 | 2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Abbvie INC. | $29.80 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.36 | 2019 | |
| Medtronic USA, INC. | $17.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurence Pearl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.